Evidence map›Paper›PMID 20501836›Full record

ArticleCancer research2010

Similar nucleotide excision repair capacity in melanocytes and melanoma cells.

Shobhan Gaddameedhi, Michael G Kemp, Joyce T Reardon, Janiel M Shields, Stephanie L Smith-Roe, William K Kaufmann, Aziz Sancar

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. UVB mutagenesis differs inLife science alliance · 2021
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Mechanisms and prevention of UV-induced melanoma.Photodermatology, photoimmunology & photomedicine · 2018
    Review
  14. Dynamic maps of UV damage formation and repair for the human genome.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.Laboratory investigation; a journal of technical methods and pathology · 2017
    Article
  16. Review
  17. Article
  18. Nucleotide excision repair by dual incisions in plants.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Article
  20. Genome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shobhan GaddameedhiDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.
Michael G Kemp
Joyce T Reardon
Janiel M Shields
Stephanie L Smith-Roe
William K Kaufmann
Aziz Sancar
UNC Lineberger Comprehensive Cancer CenterSegeberger Kliniken · DEUniversity of North Carolina at Chapel Hill · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
STRUCTURE AND FUNCTION OF UVRABC EXCISION NUCLEASER01GM032833 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SANCAR, AZIZ · 1985 to 2015
$8.9M
The System of Response to DNA Damage Suppresses Environmental MelanomagenesisP01ES014635 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAUFMANN, WILLIAM K. · 2007 to 2011
$6.7M
Cellular Responses to Environmental Insults and Risk for Melanoma DevelopmentR01ES015856 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CORDEIRO-STONE, MARILA · 2007 to 2011
$1.2M
NIEHS NIH HHS ES014635NIEHS NIH HHS ES015856NIEHS NIH HHS ES10126NIEHS NIH HHS P01 ES014635NIEHS NIH HHS P30 ES010126NIEHS NIH HHS R01 ES015856NIGMS NIH HHS GM32833NIGMS NIH HHS R01 GM032833
6 · The paper itself

Abstract

Sunlight UV exposure produces DNA photoproducts in skin that are repaired solely by nucleotide excision repair in humans. A significant fraction of melanomas are thought to result from UV-induced DNA damage that escapes repair; however, little evidence is available about the functional capacity of normal human melanocytes, malignant melanoma cells, and metastatic melanoma cells to repair UV-induced photoproducts in DNA. In this study, we measured nucleotide excision repair in both normal melanocytes and a panel of melanoma cell lines. Our results show that in 11 of 12 melanoma cell lines tested, UV photoproduct repair occurred as efficiently as in primary melanocytes. Importantly, repair capacity was not affected by mutation in the N-RAS or B-RAF oncogenes, nor was a difference observed between a highly metastatic melanoma cell line (A375SM) or its parental line (A375P). Lastly, we found that although p53 status contributed to photoproduct removal efficiency, its role did not seem to be mediated by enhanced expression or activity of DNA binding protein DDB2. We concluded that melanoma cells retain capacity for nucleotide excision repair, the loss of which probably does not commonly contribute to melanoma progression.

Indexed as

DNA RepairCells, CulturedCollagenDNA-Binding ProteinsDNA DamageDNA, NeoplasmDrug CombinationsGenes, rasHumansLamininMelanocytesMelanomaMutationProteoglycansProto-Oncogene Proteins B-rafSkin NeoplasmsBRAF protein, humanCollagenDDB2 protein, humanDNA-Binding ProteinsDNA, NeoplasmDrug CombinationsLamininmatrigelProteoglycansProto-Oncogene Proteins B-rafTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID20501836
PMCPMC2891231
OpenAlexW2144587989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.